Plenary Session: The Ribosome and Beyond
16:00-16:15: Abstract #1Speaker: TBD 16:15- 16:30: Abstract #2Speaker: TBD 16:30 – 16:45: Abstract # 3Speaker: TBD 16:45-17:15: Key Note: the ribosome as an antibacterial targetSpeaker:... Read More
Symposium: Current Trends in Antifungal Resistance
14:15 – 14:45: Candida tolerance and heteroresistanceSpeaker: Tobias Hohl, Memorial Sloan Kettering 14:45 – 15:15: The rise of Candida aurisSpeaker: Jeniel Nett, University of Wisconsin-Madison... Read More
Symposium: What is new in antimicrobial resistance detection? AST for new agents against MDRO
14:15 – 14:45: Diagnostics and the need for drug developmentSpeaker: Robin Patel, PhD, Mayo Clinic 14:45 – 15:15: Predicting novel AMR resistance mechanisms through AI... Read More
Symposium: Novel insights into β-lactam resistance in gram-positive pathogens
14:15 – 14:45: Structure-guided inhibitor discovery targeting beta-lactam antibiotic resistance mechanismsSpeaker: Natalie Strynadka PhD, University of British Columbia, Vancouver, Canada 14:45 – 15:15: Mechanisms of... Read More
Poster Session
Topics:-Mechanisms of resistance in Gram positive bacteria-Mechanisms of resistance in Gram negative bacteria-Mechanisms of resistance in fungi-New antibacterials and mechanisms of action-New targets-New antifungals-β-lactamases-PK/PD antibacterial... Read More
Symposium: Antifungal Discovery Near and Far
10:45 – 11:15: Antifungal Resistance GapsSpeaker: Luis Ostrosky-Zeichner (UTHealth Houston) Luis.Ostrosky-Zeichner@uth.tmc.edu 11:15 – 11:45: Early Discovery Approaches and Promising LeadsSpeaker: Damian Krysan (U Iowa) damian-krysan@uiowa.edu... Read More
Symposium: New generation β-lactamase inhibitors
10:45 – 11:15: β-lactamase inhibitor discoverySpeaker: Olga Lomovskaya, Qpex 11:15 – 11:45: Escape mutants against novel broad spectrum BLIs: Microbiological and clinical implicationsSpeaker: Laurent Poirel,... Read More
Symposium: Hot topics in AMR among Gram-positive bacteria
10:45 – 11:15: Update on mechanism of lipopeptide actionSpeaker: Tanja Schneider, PhD, University of Bonn, Germany 11:15 – 11:45: Collateral damage of rifaximin prophylaxis in... Read More
New Antimicrobial Agents in The Pipeline: Early Pre-Clinical Development
9:00-9:20: The antimicrobial pipeline: Success or Failure?Speaker: Karen Bush 9:20-10:30 New Antimicrobial Agents (selected from solicited abstracts)Speaker: tba
Mentoring Session: Career Paths in AMR
Moderators: Bill Shafer, PhD, Emory University and Harrison Lee, PhD, University of Pittsburgh Panel Discussion: Judith Steenbergen PhD, Scientific and Medical Affairs ConsultingEric Brown, PhD,... Read More